We are live on
!
Find out more
GHA
GW Henssler & Associates Portfolio holdings
AUM
$2.12B
1-Year Est. Return
20.77%
This Fund
S&P 500
This Quarter
Est. Return
+6.76%
1 Year Est. Return
+20.77%
3 Year Est. Return
+54.76%
5 Year Est. Return
+76.98%
10 Year Est. Return
+231.36%
AUM
$1.07B
AUM Growth
+$73.1M
(+7.3%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
28.89%
Holding
151
New
15
Increased
70
Reduced
47
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$5.79M |
| 2 |
Kroger
KR
|
+$5.36M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$4.18M |
| 4 |
Pinnacle West Capital
PNW
|
+$3.77M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$2.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$12.5M |
| 2 |
GSK
GSK
|
+$8.54M |
| 3 |
SCG
Scana
SCG
|
+$4.1M |
| 4 |
Microsoft
MSFT
|
+$813K |
| 5 |
Altria Group
MO
|
+$565K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.56% |
| 2 | Financials | 10.72% |
| 3 | Technology | 10.46% |
| 4 | Consumer Staples | 8.74% |
| 5 | Industrials | 8.71% |
Similar funds
BCM
GS
EF
AAP
IVAV
KWA
HJGA
CF
GW Henssler & Associates's Q4 2017 Portfolio in Review
As of Q4 2017, GW Henssler & Associates held 151 positions worth $1.07B, up 7.3% from $997M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
GW Henssler & Associates's Q4 2017 filing shows 15 new, 70 increased, 47 reduced and 8 closed positions. Its largest new stake was Perrigo: 67,391 shares worth $5.87M. The largest sale was Accenture, an estimated $12.5M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.
- GW Henssler & Associates's largest Q4 2017 buy was Perrigo: 67,391 shares worth $5.87M.
- GW Henssler & Associates added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $4.18M increase.
- GW Henssler & Associates's biggest Q4 2017 reduction was Accenture, cutting an estimated $12.5M.
- GW Henssler & Associates fully exited GSK in Q4 2017, selling an estimated $8.54M.
- GW Henssler & Associates's ten largest holdings make up 29% of its $1.07B portfolio in Q4 2017.
- GW Henssler & Associates opened 15 new positions and closed 8 in Q4 2017.
- GW Henssler & Associates's portfolio value rose 7.3% quarter-over-quarter to $1.07B.
Based on GW Henssler & Associates's 13F filing for Q4 2017, filed 6 Feb 2018.